The authors have advised that the study did not receive any funding. The funding statement “Medical writing was funded through a donation by Abbvie Srl” on page 3506 should be removed. The authors apologize for this error.
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123) / Megna, Matteo; Ruggiero, Angelo; Salsano, Antonia; Lauletta, Giuseppe; Portarapillo, Antonio; Torta, Ginevra; Martora, Fabrizio; Potestio, Luca. - In: CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY. - ISSN 1178-7015. - 17:(2024), pp. 1447-1448. [10.2147/CCID.S482737]
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123)
Matteo Megna;Angelo Ruggiero;Antonia Salsano;Giuseppe Lauletta;Antonio Portarapillo;Ginevra Torta;Luca Potestio
2024
Abstract
The authors have advised that the study did not receive any funding. The funding statement “Medical writing was funded through a donation by Abbvie Srl” on page 3506 should be removed. The authors apologize for this error.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
